Symbols / GRDX Stock $6.06 +2.19% GridAI Technologies Corp.

Healthcare • Biotechnology • United Kingdom • NCM
GRDX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Jason David Sawyer
Exch · Country NCM · United Kingdom
Market Cap 40.32M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO Oct 11, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -4.14
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 6.65M
Shs Float —
Insider Own 8.57%
Instit Own 5.24%
Short Float 0.97%
Short Ratio 0.40
Short Interest 58.12K
52W High 6.93
vs 52W High -12.54%
52W Low 1.08
vs 52W Low 461.11%
Beta —
Impl. Vol. —
Rel Volume 0.29
Avg Volume 119.66K
Volume 34.96K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $5.93
Price $6.06
Change 2.19%
About

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$6.06
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$6.06
Low
—
High
—
Mean
—
News
RSS: Latest GRDX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-31 BORKOWSKI EDWARD J Director — 40,000 $0.00 $0
2025-12-31 UPPAL MANPREET Director — 40,000 $0.00 $0
2025-12-31 PURSGLOVE GEORDAN GARRETT Director — 40,000 $0.00 $0
2025-12-22 SKOWRON ANNA Chief Financial Officer — 65,000 $0.00 $0
2025-12-22 SAWYER JASON DAVID Chief Executive Officer — 40,000 $0.00 $0
2025-01-06 ROMANO SARAH M. Chief Financial Officer — 727 $0.64 $465
2024-10-09 ROMANO SARAH M. Chief Financial Officer — 476 $0.45 $212
2024-07-02 SAPIRSTEIN JAMES E Chief Executive Officer — 1,289 $1.07 $1,379
2024-07-02 ROMANO SARAH M. Chief Financial Officer — 621 $1.07 $664
2024-06-11 KHOSLA CHAITAN S Director — 24,889 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.04
0.00
0.00
0.00
Operating Revenue
0.04
0.00
0.00
0.00
Cost Of Revenue
0.69
0.00
—
—
Reconciled Cost Of Revenue
0.69
0.00
—
—
Gross Profit
-0.66
0.00
—
—
Operating Expense
6.43
-58.86%
15.62
-0.95%
15.77
+24.39%
12.68
Research And Development
0.93
+2.38%
0.90
-82.04%
5.03
+628.13%
0.69
Selling General And Administration
5.50
-62.63%
14.72
+37.06%
10.74
-10.42%
11.99
General And Administrative Expense
5.50
-62.63%
14.72
+37.06%
10.74
-10.42%
11.99
Other Gand A
5.50
-62.63%
14.72
+37.06%
10.74
-10.42%
11.99
Total Expenses
7.12
-54.42%
15.62
-0.95%
15.77
+24.39%
12.68
Operating Income
-7.08
+54.66%
-15.62
+0.95%
-15.77
-24.39%
-12.68
Total Operating Income As Reported
-7.08
+54.66%
-15.62
+0.95%
-15.77
-24.39%
-12.68
EBITDA
-6.51
+58.20%
-15.57
+1.08%
-15.74
-7.93%
-14.58
Normalized EBITDA
-6.51
+58.20%
-15.57
+1.08%
-15.74
-22.28%
-12.87
Reconciled Depreciation
0.57
+1074.18%
0.05
+67.20%
0.03
+0.01%
0.03
EBIT
-7.08
+54.66%
-15.62
+0.95%
-15.77
-7.92%
-14.61
Total Unusual Items
—
—
0.00
+100.00%
-1.71
Total Unusual Items Excluding Goodwill
—
—
0.00
+100.00%
-1.71
Special Income Charges
—
—
0.00
+100.00%
-1.71
Impairment Of Capital Assets
—
—
—
0.00
Net Income
-6.39
+64.60%
-18.06
-14.34%
-15.79
-7.97%
-14.63
Pretax Income
-6.64
+57.49%
-15.62
+1.11%
-15.79
-7.97%
-14.63
Net Non Operating Interest Income Expense
-0.49
-56195.43%
0.00
+104.39%
-0.02
-167.04%
-0.01
Interest Expense Non Operating
—
—
0.02
+41.46%
0.02
Net Interest Income
-0.49
-56195.43%
0.00
+104.39%
-0.02
-167.04%
-0.01
Interest Expense
—
—
0.02
+41.46%
0.02
Interest Income Non Operating
—
—
0.00
-69.92%
0.01
Interest Income
—
—
0.00
-69.92%
0.01
Other Income Expense
0.93
+67698.04%
0.00
+132.62%
-0.00
+99.78%
-1.94
Other Non Operating Income Expenses
0.93
+67698.04%
0.00
+132.62%
-0.00
+98.19%
-0.23
Gain On Sale Of Business
—
—
0.00
+100.00%
-1.71
Tax Provision
-0.40
0.00
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-6.55
+63.71%
-18.06
-14.34%
-15.79
-7.97%
-14.63
Net Income From Continuing Operation Net Minority Interest
-6.08
+61.07%
-15.62
+1.11%
-15.79
-7.97%
-14.63
Net Income From Continuing And Discontinued Operation
-6.39
+64.60%
-18.06
-14.34%
-15.79
-7.97%
-14.63
Net Income Continuous Operations
-6.24
+60.04%
-15.62
+1.11%
-15.79
-7.97%
-14.63
Net Income Discontinuous Operations
-0.31
+87.20%
-2.44
0.00
—
Minority Interests
0.16
0.00
—
—
Normalized Income
-6.08
+61.07%
-15.62
+1.11%
-15.79
-22.27%
-12.92
Net Income Common Stockholders
-6.73
+63.23%
-18.30
-13.64%
-16.10
-7.55%
-14.97
Otherunder Preferred Stock Dividend
—
—
0.00
-100.00%
0.05
Diluted EPS
-4.16
+73.98%
-15.99
+88.87%
-143.64
+88.52%
-1,250.82
Basic EPS
-4.16
+73.98%
-15.99
+88.87%
-143.64
+88.52%
-1,250.82
Basic Average Shares
1.62
+41.20%
1.14
+921.27%
0.11
+836.62%
0.01
Diluted Average Shares
1.62
+41.20%
1.14
+921.27%
0.11
+836.62%
0.01
Diluted NI Availto Com Stockholders
-6.73
+63.23%
-18.30
-13.64%
-16.10
-7.55%
-14.97
Preferred Stock Dividends
0.34
+39.95%
0.24
-21.80%
0.31
+4.05%
0.30
Total Other Finance Cost
0.49
+56195.43%
-0.00
-104.39%
0.02
—
Line Item Trend 2023-12-31
Total Assets
6.88
Current Assets
4.96
Cash Cash Equivalents And Short Term Investments
3.71
Cash And Cash Equivalents
3.71
Receivables
0.00
Accounts Receivable
—
Other Receivables
—
Taxes Receivable
—
Prepaid Assets
1.24
Assets Held For Sale Current
0.00
Other Current Assets
—
Total Non Current Assets
1.93
Net PPE
0.21
Gross PPE
0.28
Accumulated Depreciation
-0.07
Properties
0.00
Machinery Furniture Equipment
0.06
Other Properties
0.20
Leases
0.03
Goodwill And Other Intangible Assets
1.68
Goodwill
1.68
Other Intangible Assets
—
Non Current Prepaid Assets
0.01
Other Non Current Assets
0.02
Total Liabilities Net Minority Interest
3.28
Current Liabilities
3.13
Payables And Accrued Expenses
2.45
Payables
1.62
Accounts Payable
0.55
Other Payable
—
Dividends Payable
1.07
Current Accrued Expenses
0.83
Current Debt And Capital Lease Obligation
0.68
Current Debt
0.61
Current Capital Lease Obligation
0.07
Current Deferred Liabilities
—
Other Current Liabilities
0.00
Total Non Current Liabilities Net Minority Interest
0.15
Long Term Debt And Capital Lease Obligation
0.15
Long Term Capital Lease Obligation
0.15
Tradeand Other Payables Non Current
—
Non Current Deferred Liabilities
—
Non Current Deferred Taxes Liabilities
—
Other Non Current Liabilities
—
Stockholders Equity
3.60
Common Stock Equity
3.60
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.52
Ordinary Shares Number
0.52
Treasury Shares Number
0.00
Additional Paid In Capital
187.93
Retained Earnings
-184.33
Gains Losses Not Affecting Retained Earnings
—
Minority Interest
—
Other Equity Adjustments
—
Total Equity Gross Minority Interest
3.60
Total Capitalization
3.60
Working Capital
1.82
Invested Capital
4.22
Total Debt
0.83
Net Debt
—
Capital Lease Obligations
0.21
Net Tangible Assets
1.92
Tangible Book Value
1.92
Current Notes Payable
0.61
Dueto Related Parties Current
—
Foreign Currency Translation Adjustments
—
Interest Payable
—
Line Of Credit
0.00
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.70
+38.13%
-9.22
+25.53%
-12.38
+44.60%
-22.34
Cash Flow From Continuing Operating Activities
-5.70
+38.13%
-9.22
+25.53%
-12.38
+44.60%
-22.34
Net Income From Continuing Operations
-6.55
+63.71%
-18.06
-14.34%
-15.79
-7.97%
-14.63
Depreciation Amortization Depletion
0.57
+1074.18%
0.05
+67.20%
0.03
+0.01%
0.03
Depreciation
0.57
+1074.18%
0.05
+67.20%
0.03
+0.01%
0.03
Amortization Cash Flow
—
—
—
0.00
Depreciation And Amortization
0.57
+1074.18%
0.05
+67.20%
0.03
+0.01%
0.03
Amortization Of Intangibles
—
—
—
0.00
Other Non Cash Items
0.49
-91.25%
5.63
+3486.78%
0.16
-43.40%
0.28
Stock Based Compensation
0.73
+16.21%
0.63
-39.30%
1.04
+35.28%
0.77
Asset Impairment Charge
—
—
—
0.00
Operating Gains Losses
-0.61
—
—
1.71
Gain Loss On Investment Securities
—
—
—
0.20
Net Foreign Currency Exchange Gain Loss
—
—
0.00
-100.00%
1.71
Change In Working Capital
-0.34
-113.61%
2.53
+15.46%
2.19
+120.86%
-10.50
Change In Receivables
-1.62
0.00
-100.00%
0.09
+200.00%
-0.09
Changes In Account Receivables
-0.42
0.00
—
—
Change In Prepaid Assets
0.14
-85.80%
1.01
+40.72%
0.72
+575.68%
-0.15
Change In Payables And Accrued Expense
0.38
-74.51%
1.48
+2.23%
1.45
+114.31%
-10.15
Change In Accrued Expense
-0.09
+41.90%
-0.16
-109.91%
1.62
+2313.96%
-0.07
Change In Payable
0.47
-71.34%
1.64
+1092.29%
-0.17
+98.35%
-10.07
Change In Account Payable
0.47
-71.34%
1.64
+1092.29%
-0.17
+91.66%
-1.99
Change In Other Working Capital
0.76
+592.73%
0.11
+1485.00%
-0.01
—
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
-0.00
+93.62%
-0.08
-16.61%
-0.07
+40.72%
-0.11
Investing Cash Flow
0.32
+266.89%
0.09
+117.63%
-0.50
0.00
Cash Flow From Continuing Investing Activities
0.32
+266.89%
0.09
+117.63%
-0.50
0.00
Net PPE Purchase And Sale
—
—
—
0.00
Purchase Of PPE
—
—
—
0.00
Sale Of PPE
—
—
—
—
Capital Expenditure
—
—
-0.50
—
Net Business Purchase And Sale
0.32
+266.89%
0.09
0.00
—
Gain Loss On Sale Of Business
-0.61
0.00
—
—
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.50
0.00
Purchase Of Intangibles
—
0.00
+100.00%
-0.50
0.00
Financing Cash Flow
5.89
+5.52%
5.58
-63.35%
15.23
-3.26%
15.74
Cash Flow From Continuing Financing Activities
5.89
+5.52%
5.58
-63.35%
15.23
-3.26%
15.74
Net Issuance Payments Of Debt
3.00
+565.42%
-0.64
-6.81%
-0.60
+5.89%
-0.64
Issuance Of Debt
3.00
0.00
—
—
Repayment Of Debt
0.00
+100.00%
-0.64
-6.81%
-0.60
+5.89%
-0.64
Long Term Debt Issuance
3.00
0.00
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
3.00
0.00
—
—
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
0.00
+100.00%
-0.64
-6.81%
-0.60
+5.89%
-0.64
Net Short Term Debt Issuance
0.00
+100.00%
-0.64
-6.81%
-0.60
+5.89%
-0.64
Net Common Stock Issuance
3.47
-44.22%
6.23
-60.67%
15.83
-31.32%
23.05
Proceeds From Stock Option Exercised
0.17
+369784.44%
0.00
-93.15%
0.00
-98.64%
0.05
Net Other Financing Charges
-0.75
—
—
-6.91
Changes In Cash
0.51
+114.37%
-3.55
-251.06%
2.35
+135.56%
-6.60
Effect Of Exchange Rate Changes
0.20
0.00
0.00
+100.00%
-0.26
Beginning Cash Position
0.18
-95.04%
3.73
+169.66%
1.38
-83.22%
8.25
End Cash Position
0.90
+386.39%
0.18
-95.04%
3.73
+169.66%
1.38
Free Cash Flow
-5.70
+38.13%
-9.22
+28.42%
-12.88
+42.37%
-22.34
Interest Paid Supplemental Data
0.00
-100.00%
0.04
+61.00%
0.02
+41.46%
0.02
Income Tax Paid Supplemental Data
—
—
—
—
Common Stock Issuance
3.47
-44.22%
6.23
-60.67%
15.83
-31.32%
23.05
Issuance Of Capital Stock
3.47
-44.22%
6.23
-60.67%
15.83
-31.91%
23.25
Net Preferred Stock Issuance
—
—
0.00
-100.00%
0.20
Preferred Stock Issuance
—
—
0.00
-100.00%
0.20
Sale Of Business
0.32
+266.89%
0.09
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category